Man Group plc - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
Man Group plc ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$3,900,000
-14.2%
212,209
-14.4%
0.02%
-5.6%
Q3 2020$4,545,000
+181.9%
247,838
+130.2%
0.02%
+125.0%
Q2 2020$1,612,000
-27.3%
107,680
-23.2%
0.01%
-42.9%
Q1 2020$2,218,000140,1800.01%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q1 2021
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 38,300$555,0000.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 34,571$501,0000.01%
Acrospire Investment Management LLC 300$4,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 25,798$374,0000.00%
RHUMBLINE ADVISERS 14,614$212,0000.00%
BlackRock Investment Management, LLC 47,237$685,0000.00%
BlackRock Fund Advisors 336,772$4,883,0000.00%
NORTHERN TRUST CORP 135,559$1,966,0000.00%
NEW YORK STATE COMMON RETIREMENT FUND 11,406$165,0000.00%
STRS OHIO 1,500$21,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders